Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ).
Neuroscientific Biopharmaceuticals Ltd. announced that McRae Technology Pty Ltd has ceased to be a substantial holder in the company following an off-market sale of 3,500,000 ordinary shares valued at $612,500. This change in substantial holding may impact the company’s shareholder structure and could influence investor perceptions and market dynamics.
More about Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd. operates in the biopharmaceutical industry, focusing on developing therapeutic treatments for neurological disorders. The company aims to address unmet medical needs within the neuroscience sector.
Average Trading Volume: 648,929
Technical Sentiment Signal: Buy
Current Market Cap: A$59.86M
See more data about NSB stock on TipRanks’ Stock Analysis page.